Work on a vaccine for the coronavirus is being conducted in many countries

The developers plan two months to start testing on animals and clinical tests on humans to start in six months.

Scientists from Singapore has begun to develop a universal vaccine against coronavirus COVID-19, which within three weeks could be modified in the case of mutations of the virus. About this newspaper the Straits Times, with reference to the head of a local company Esco Aster Lin Sanlian Tuesday, may 19.

According to him, “in their work, scientists are trying to combine the antibodies produced when exposed to the coronavirus SARS-CoV-2, with protein-based influenza virus”.

The expert noted that “if there is a protein base can make the immune system respond to the virus and develop antibodies”.

The head of the company also said that “in the case of a mutation of the coronavirus vaccine being developed will allow scientists for two to three weeks to combine antibodies with the emergence of a new strain”.

The developers plan two months to start testing on animals and clinical tests on humans to start in six months.

It became known yesterday that the US clinical biotech company Moderna, Inc. successfully completed the first phase of human trials of the drug mRNA-1273 for a vaccine against coronavirus.

Earlier in Israel has successfully tested a vaccine against coronavirus. If the study goes according to plan, the vaccine against the coronavirus will be ready in a year or even sooner.

News from